| American Association of Clinical Endocrinology
activity Sleep Mental health Smoking V. Lifestyle Recommendations Intensity Stratified by Degree of CV Risk, Type of Dyslipidemia, and Related Complications General recommendations Whole-food, plant-based, Mediterranean, and DASH diets recommended Physical activity Ž3 times/week Reduce/break up prolonged sitting Sleep duration 6-8 hours/night
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
AACE COMPREHENSIVE TYPE 2 DIABETES 2 0
pro.aace.comTYPE 2 DIABETES MANAGEMENT ALGORITHM 1. Lifestyle modification underlies all therapy (e.g., weight control, physical activity, sleep, etc.) ... Lifestyle Therapy: Physician/RD counseling, web/remote program, structured multidisciplinary program Medical Therapy (BMI 2 27): Surgical Therapy (BMI 2 35): Endoscopic procedures, gastric banding ...
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS …
pro.aace.comduration of diabetes, presence of comorbidities, diabetic complications, and hypoglycemia risk • Fied regimen Increase TDD by 2 U • Adustable regimen • FBG 180 mg/dL add 20 of TDD • FBG 140180 mg/dL add 10 of TDD • TDD 0.30.5 U/gFBG 110139 mg/dL add 1 unit • If hypoglycemia reduce TDD by • BG 0 mg/dL 10 20 • BG 40 mg/dL 20 40
AMERICAN ASSOCIATION OF CLINICAL …
pro.aace.comcrosses medical, social, and economic lines. These guide-lines have been developed by the American Association of Clinical Endocrinologists (AACE) with hopes of reduc-ing the risk of osteoporosis-related fractures and thereby maintaining the quality of life for people with osteopo-rosis. The guidelines use the best evidence, taking into
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION …
pro.aace.comachieve treatment goals. When targeting triglyceride levels, the desirable goal is <150 mg/dL. Statin therapy should be combined with a fibrate, prescription-grade omega-3 fatty acid, and/or niacin to reduce triglycerides in all patients with triglycerides ≥500 …
Initiating and Intensifying Insulin Therapy in Patients ...
pro.aace.comcontrol and preserve beta-cell function in patients with newly diagnosed T2D and severe, symptomatic hyperglycemia. 1-3 • By treating patients with insulin before diabetes has progressed (typically for 2 weeks to 3 months), glucolipotoxicity is rapidly reversed, and beta -cells are given the chance to “rest.” 1-3
IV Insulin for Hospitalized Patients
pro.aace.comhospitalized patients has led to updates in clinical practice guidelines1 • Several published guidelines address the management of hyperglycemia in hospitalized patients, in both critical and non-critical settings2-7 1. Lansang MC, et al. Cleve Clin J Med. 2016;83(5 Suppl 1):S34-S43. 2. Qaseem A, et al. Am J Med Qual. 2014;29(2):95-98. 3.
Related documents
Update οn the diagnosis and management of systemic …
ard.bmj.comactivity or remission has the potential to decrease the frequency and severity of lupus flares and resulting damage. ACR, American College of Rheumatology; SLE, systemic lupus erythematosus. Figure 2 (A) Prevalence and disease severity in SLE. In community-based registries, most patients are middle-aged women and approximately
Diagnosis and Evaluation of Heart Failure
www.aafp.orgJun 15, 2012 · Collagen vascular disease (e.g., systemic lupus erythematosus, scleroderma) Endocrine/metabolic disorders (e.g., thyroid disease, diabetes mellitus, ... IV Discomfort with any activity Heart ...
Fatigue Severity Scale (FSS)
www.med.upenn.edution, physical activity, work, family, and social life, and asking respondents to rate the ease with which they are fatigued and the degree to which the symptom poses a problem for them. Population or f Testing The scale was initially validated in a population of patients with multiple sclerosis and systemic lupus erythematosus.
Systemic Lupus Erythematosus Disease Activity Index 2000
www.jrheum.orgThe Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) was developed and validated as a clinical index for the measurement of disease activity in SLE and has been used as a global measure of disease activity in SLE since its intro-duction in 19851,2. This index was modeled on clinicians’ global judgment.
Lupus eritematoso sistémico pediátrico
www.aeped.esSystemic lupus erythematosus ABSTRACT Childhood-onset systemic lupus erythematosus (SLE) corresponds to approximately 20% of the total patients with SLE. Disease activity tends to be greater in paediatric patients, leading to increased morbidity and earlier damage. Renal and neurologic involvement are more frequent in childhood-onset SLE
Anti-phospholipid Antibody Testing (Lupus Anticoagulant ...
clevelandcliniclabs.comalso known as lupus anticoagulants due to their prevalence in patients with systemic lupus erythematosus — are extremely heterogeneous and are directed against a wide variety of anionic phospholipids, including cardiolipin, ß2 glycoprotein 1 (B2GP1), cell-membrane phosphatidylserine, and many others. Paradoxically, APAs prolong clot-based
2019 update of the EULAR recommendations for the ...
ard.bmj.comTable 1 Recommendations for the management of patients with systemic lupus erythematosus overarching principles SLE is a multisystem disease—occasionally limited to one or few organs—diagnosed on clinical grounds in the presence of characteristic serological abnormalities.